Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

SakuraBead - pain agnostic treatment for everyone

Objectif

At CrannMed we are developing resorbable embolic microspheres to unlock the growing potential of vascular embolization. We call this technology SakuraBead.

Our new approach to the treatment of chronic MSK pain is based on a recent unifying understanding of the mechanism of the disease.
Previously chronic MSK pain was considered to be a wear and tear disease, but recent research suggests that the underlying root cause is a self-propagating chronic inflammatory process. This inflammatory process is characterized by the presence of neo-vessels in the tissue surrounding the site of pain. Deactivation of these neo-vessels via embolization treats the mechanism of action of the disease and disrupts the pain pathway promising years of pain free living. Effectively, our technology can turn off the mechanism of pain by interrupting the inflammatory process that sustains it. The technology has been validated in a human clinical studies focused on knee osteoarthritis which resulted in significant and long term pain relief.

SakuraBead will be the world’s first embolic that can be delivered by direct injection in an outpatient setting. Should the technology achieve its full potential it can replace upwards of 50 million steroid injections per year.
Clinical validation of the technology in expanded anatomical locations is a large part of the project.

Champ scientifique (EuroSciVoc)

Ce projet n'a pas encore été classé par EuroSciVoc.
Proposez les domaines scientifiques qui vous semblent les plus pertinents et aidez-nous à améliorer notre service de classification.

Mots‑clés

Programme(s)

Thème(s)

Régime de financement

HORIZON-EIC-ACC - HORIZON EIC Accelerator

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) HORIZON-EIC-2025-ACCELERATOR-02

Voir tous les projets financés au titre de cet appel

Coordinateur

CRANNMED LTD
Contribution nette de l'UE
€ 2 366 802,08
Adresse
TRUSKEY BARNA
H91XW6Y Galway
Irlande
PME
Oui
Région
Ireland Northern and Western West
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Liens
Coût total
Aucune donnée